speb/financial-data huggingface dataset:
MEDICO.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 62492000.00
MEDICO.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 106757000.00
MEDICO.NS balance_sheet (annual, 2025-03-31) — Share Issued: 82984000.00
MEDICO.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 82984000.00
MEDICO.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
MEDICO.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
MEDICO.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 624689000.00
MEDICO.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 624689000.00
MEDICO.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 624027000.00
MEDICO.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 624027000.00
MEDICO.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MEDICO.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MEDICO.NS income_statement (annual, 2025-03-31) — Tax Provision: 34105000.00
MEDICO.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 13577000.00
MEDICO.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.25
MEDICO.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.24
MEDICO.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 94428000.00
MEDICO.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 94428000.00
MEDICO.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -38024000.00
MEDICO.NS balance_sheet (annual, 2025-03-31) — Total Assets: 1197993000.00
MEDICO.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 1197993000.00
MEDICO.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 624689000.00
MEDICO.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 624689000.00
MEDICO.NS balance_sheet (annual, 2025-03-31) — Total Debt: 146996000.00
MEDICO.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 146996000.00
MEDICO.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 624689000.00
MEDICO.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 624689000.00
MEDICO.NS income_statement (annual, 2025-03-31) — Total Expenses: 1389678000.00
MEDICO.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 354036000.00
MEDICO.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 573304000.00
MEDICO.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 573304000.00
MEDICO.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 231242000.00
MEDICO.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 231242000.00
MEDICO.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3689000.00
MEDICO.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3689000.00
MEDICO.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 3041000.00
MEDICO.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 18310000.00
MEDICO.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 18310000.00
MEDICO.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
MEDICO.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
MEDICO.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MEDICO.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MEDICO.NS balance_sheet (annual, 2025-03-31) — Work In Process: 59227000.00
MEDICO.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 59227000.00
MEDICO.NS balance_sheet (annual, 2025-03-31) — Working Capital: 397136000.00
MEDICO.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 397136000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 88559000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 382515000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 82650000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.22
MEDICO.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 273386000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 7690000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 7690000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 82650000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.22
MEDICO.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 18183000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — EBIT: 27153000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — EBITDA: 34843000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 109129000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 2811000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 2811000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Net Income: 18183000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 18183000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 18183000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 18183000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 18183000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 18183000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -2811000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -2811000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 34843000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 18183000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Operating Income: 20570000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 382515000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 6581000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 63833000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 24342000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 273386000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 7690000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 6158000.00
MEDICO.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
MEDICO.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 361945000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 102064000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 526352000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 536063000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 573752000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 11181000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 82845161.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 0.31
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 6280000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 165968000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 2670000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 17635000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 165968000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 668576000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 4677000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 404443000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 1137970000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 5339000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 118992000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 124331000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 704052000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 7336000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 7336000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 82845161.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.31
MEDICO.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 25682000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — EBIT: 37092000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — EBITDA: 44428000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 512000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 212653000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 121909000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 2351000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 2351000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 413819000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 787568000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 11181000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 941000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 0.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 941000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 116322000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Net Income: 25682000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 25682000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 25682000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 25682000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 25682000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 25682000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -2351000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -2351000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 212653000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 668064000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 348000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 0.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 44428000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 25682000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Operating Income: 19845000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 526352000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 82984000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 129953000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 42353000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 502608000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 512000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 10904000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 17248000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 76628000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 207976000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 2811000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 14965000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Payables: 537368000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 34741000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 404443000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 7336000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 82984000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 668576000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 668064000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 9059000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.26
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 1373569000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 668576000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 125272000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 668576000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 506507000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 704993000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 235598000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 941000.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 1305000.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
MEDICO.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 0.00
MEDICO.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 433918000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 110329000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 586829000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 82065714.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.35
MEDICO.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 441082000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 7902000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 7902000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 82065714.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.35
MEDICO.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 28723000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — EBIT: 42186000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — EBITDA: 50088000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 145747000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 3863000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 3863000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Net Income: 28723000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 28723000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 28723000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 28723000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 28723000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 28723000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -3863000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -3863000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 50088000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 28723000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Operating Income: 35418000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 586829000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 6768000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 81135000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 38323000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 441082000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 7902000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 9600000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.25
MEDICO.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 551411000.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
MEDICO.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
MEDICO.NS income_statement (annual, 2026-03-31) — +Operating Expense: 411173000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 110222000.00
MEDICO.NS income_statement (annual, 2026-03-31) — +Total Revenue: 2063773000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 568077000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 493283000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 493283000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 819924000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 819924000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 8837000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 8837000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 82487324.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 0.71
MEDICO.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 10949000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -44897000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 3688000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 3688000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 165968000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 165968000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 19069000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 19069000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 37564000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 37564000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -32894000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -28857000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 64819000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Change In Payable: 146149000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -252373000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -103156000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 8119000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Common Stock: 165968000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 165968000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 754745000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 754745000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 25733000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 25733000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 1513276000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 394363000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Current Assets: 1289176000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 1289176000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 3688000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 3688000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Current Debt: 185490000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 185490000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 189178000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 189178000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 776426000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 776426000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Deferred Tax: 49444000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Depreciation: 30946000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 30946000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 30946000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 8019000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 30946000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 8019000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 82487324.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.71
MEDICO.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 131152000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 58566000.00
MEDICO.NS income_statement (annual, 2026-03-31) — EBIT: 198659000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — EBIT: 92230000.00
MEDICO.NS income_statement (annual, 2026-03-31) — EBITDA: 229605000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — EBITDA: 100249000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — End Cash Position: 19069000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -5500000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 13845000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -82000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 364000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 364000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 229491000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 229491000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Gross Profit: 550497000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 173714000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Interest Expense: 18063000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 9038000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 18063000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 9038000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 1349000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Inventory: 300158000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 300158000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 943098000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 943098000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -45123000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 8837000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 8837000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 0.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 0.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 2863000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 2863000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2863000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2863000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Net Debt: 169284000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 169284000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Net Income: 131152000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Net Income: 58566000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 131152000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 58566000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 131152000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 58566000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 131152000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 58566000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 131152000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 58566000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 131152000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 131152000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 58566000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Net Interest Income: -18063000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -9038000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -2367000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -18063000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -9038000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -1000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Net PPE: 229491000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 229491000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -44247000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 754381000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 754381000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 3954000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 3954000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 229605000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 100249000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Normalized Income: 131152000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 58566000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 58742000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Operating Income: 139324000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Operating Income: 63492000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Operating Revenue: 2063773000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 568077000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 82984000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 82984000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 128705000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 128705000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 66419000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 66419000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 588777000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 588777000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 364000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 364000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -2298000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 2211000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 2211000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: -1000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: -1000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 59335000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 28739000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 306245000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 84649000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Other Properties: 203758000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 203758000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 2825000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 2825000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 18495000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 18495000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Payables: 520829000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Payables: 520829000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Pretax Income: 180596000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 83192000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 3290000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -3937000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -44897000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 1513276000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 394363000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 30946000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 8019000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 1570000.00
MEDICO.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 650000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Share Issued: 82984000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 82984000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 754745000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 754745000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 754381000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 754381000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
MEDICO.NS income_statement (annual, 2026-03-31) — Tax Provision: 49444000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 24626000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.27
MEDICO.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.30
MEDICO.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -50555000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Total Assets: 1534033000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 1534033000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 757608000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 757608000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Total Debt: 192041000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 192041000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 754745000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 754745000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Total Expenses: 1924449000.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 504585000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 779288000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 779288000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 244857000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 244857000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2862000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2862000.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 27546000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 27546000.00
MEDICO.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 0.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
MEDICO.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MEDICO.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MEDICO.NS balance_sheet (annual, 2026-03-31) — Working Capital: 512750000.00
MEDICO.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 512750000.00
MEDP cash_flow (annual, 2021-12-31) — Capital Expenditure Reported: -28271000.00
MEDP balance_sheet (annual, 2021-12-31) — Line Of Credit: 0.00
MEDP cash_flow (annual, 2021-12-31) — Long Term Debt Payments: 0.00
MEDP cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 0.00
MEDP balance_sheet (annual, 2021-12-31) — Prepaid Assets: 43176000.00
MEDP income_statement (annual, 2022-12-31) — +Operating Expense: 153741000.00
MEDP income_statement (annual, 2022-12-31) — +Total Revenue: 1459996000.00
MEDP balance_sheet (annual, 2022-12-31) — Accounts Payable: 33069000.00
MEDP balance_sheet (annual, 2022-12-31) — Accounts Receivable: 213169000.00
MEDP balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -62116000.00
MEDP balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 770794000.00
MEDP income_statement (annual, 2022-12-31) — Amortization: 3352000.00
MEDP cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 3352000.00
MEDP cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 3352000.00
MEDP income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 3352000.00
MEDP income_statement (annual, 2022-12-31) — Basic Average Shares: 32388000.00
MEDP income_statement (annual, 2022-12-31) — Basic EPS: 7.57
MEDP cash_flow (annual, 2022-12-31) — Beginning Cash Position: 461304000.00
MEDP balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 13594000.00
MEDP cash_flow (annual, 2022-12-31) — Capital Expenditure: -36879000.00
MEDP balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 138867000.00
MEDP balance_sheet (annual, 2022-12-31) — Capital Stock: 309000.00
MEDP balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 28265000.00
MEDP balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 28265000.00
MEDP cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -775775000.00
MEDP cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -38742000.00
MEDP cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 388050000.00
MEDP cash_flow (annual, 2022-12-31) — Change In Account Payable: 6431000.00
MEDP cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 52476000.00
MEDP cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -15899000.00
MEDP cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 140142000.00
MEDP cash_flow (annual, 2022-12-31) — Change In Payable: 6431000.00
MEDP cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 58907000.00
MEDP cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -10175000.00
MEDP cash_flow (annual, 2022-12-31) — Change In Receivables: -66920000.00
MEDP cash_flow (annual, 2022-12-31) — Change In Working Capital: 106055000.00
MEDP cash_flow (annual, 2022-12-31) — Changes In Cash: -426467000.00
MEDP balance_sheet (annual, 2022-12-31) — Common Stock: 309000.00
MEDP balance_sheet (annual, 2022-12-31) — Common Stock Equity: 386387000.00
MEDP cash_flow (annual, 2022-12-31) — Common Stock Payments: -847849000.00
MEDP balance_sheet (annual, 2022-12-31) — Construction In Progress: 10518000.00
MEDP income_statement (annual, 2022-12-31) — Cost Of Revenue: 1027558000.00
MEDP balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 138928000.00
MEDP balance_sheet (annual, 2022-12-31) — Current Assets: 333962000.00
MEDP balance_sheet (annual, 2022-12-31) — Current Debt: 50000000.00
MEDP balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 50000000.00
MEDP balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 462729000.00
MEDP balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 462729000.00
MEDP balance_sheet (annual, 2022-12-31) — Current Liabilities: 803470000.00
MEDP cash_flow (annual, 2022-12-31) — Deferred Income Tax: -23014000.00
MEDP cash_flow (annual, 2022-12-31) — Deferred Tax: -23014000.00
MEDP cash_flow (annual, 2022-12-31) — Depreciation: 18989000.00
MEDP cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 22341000.00
MEDP income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 22341000.00
MEDP cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 22341000.00
MEDP income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 22341000.00
MEDP income_statement (annual, 2022-12-31) — Depreciation Income Statement: 18989000.00
MEDP income_statement (annual, 2022-12-31) — Diluted Average Shares: 33671000.00
MEDP income_statement (annual, 2022-12-31) — Diluted EPS: 7.28
MEDP income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 245211000.00
MEDP income_statement (annual, 2022-12-31) — EBIT: 278697000.00
MEDP income_statement (annual, 2022-12-31) — EBITDA: 301038000.00
MEDP cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -6572000.00
MEDP cash_flow (annual, 2022-12-31) — End Cash Position: 28265000.00
MEDP cash_flow (annual, 2022-12-31) — Financing Cash Flow: -775775000.00
MEDP cash_flow (annual, 2022-12-31) — Free Cash Flow: 351171000.00
MEDP income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 3859000.00
MEDP balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -12392000.00
MEDP balance_sheet (annual, 2022-12-31) — Goodwill: 662396000.00
MEDP balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 700404000.00
MEDP balance_sheet (annual, 2022-12-31) — Gross PPE: 311033000.00
MEDP income_statement (annual, 2022-12-31) — Gross Profit: 432438000.00
MEDP cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 50164000.00
MEDP cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 2935000.00
MEDP balance_sheet (annual, 2022-12-31) — Invested Capital: 436387000.00
MEDP cash_flow (annual, 2022-12-31) — Investing Cash Flow: -38742000.00
MEDP cash_flow (annual, 2022-12-31) — Issuance Of Debt: 324200000.00
MEDP balance_sheet (annual, 2022-12-31) — Land And Improvements: 2410000.00
MEDP balance_sheet (annual, 2022-12-31) — Line Of Credit: 50000000.00
MEDP balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 138867000.00
MEDP balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 138867000.00
MEDP balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 113592000.00
MEDP cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -847849000.00
MEDP balance_sheet (annual, 2022-12-31) — Net Debt: 21735000.00
MEDP income_statement (annual, 2022-12-31) — Net Income: 245368000.00
MEDP income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 245211000.00
MEDP income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 245368000.00
MEDP income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 245368000.00
MEDP income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 245368000.00
MEDP cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 245368000.00
MEDP income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 245368000.00
MEDP income_statement (annual, 2022-12-31) — Net Interest Income: -2905000.00
MEDP cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 50000000.00
MEDP income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -2905000.00
MEDP cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -1863000.00
MEDP balance_sheet (annual, 2022-12-31) — Net PPE: 248917000.00
MEDP cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -36879000.00
MEDP cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 50000000.00
MEDP balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -314017000.00
MEDP balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 48083000.00
MEDP balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 1070000.00
MEDP balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 48083000.00
MEDP balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 1070000.00
MEDP income_statement (annual, 2022-12-31) — Normalized EBITDA: 297179000.00
MEDP income_statement (annual, 2022-12-31) — Normalized Income: 242022247.00
MEDP cash_flow (annual, 2022-12-31) — Operating Cash Flow: 388050000.00
MEDP income_statement (annual, 2022-12-31) — Operating Income: 278697000.00
MEDP income_statement (annual, 2022-12-31) — Operating Revenue: 1459996000.00
MEDP balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 31091694.00
MEDP balance_sheet (annual, 2022-12-31) — Other Current Assets: 52293000.00
MEDP balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 47547000.00
MEDP balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -12392000.00
MEDP income_statement (annual, 2022-12-31) — Other Income Expense: 7068000.00
MEDP balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 38008000.00
MEDP cash_flow (annual, 2022-12-31) — Other Non Cash Items: 15888000.00
MEDP balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 21129000.00
MEDP balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 22701000.00
MEDP income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 3209000.00
MEDP balance_sheet (annual, 2022-12-31) — Other Properties: 170919000.00
MEDP balance_sheet (annual, 2022-12-31) — Other Receivables: 40405000.00
MEDP income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 157000.00
MEDP balance_sheet (annual, 2022-12-31) — Payables: 33069000.00
MEDP balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 171997000.00
MEDP balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 71197000.00
MEDP balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
MEDP income_statement (annual, 2022-12-31) — Pretax Income: 282860000.00
MEDP cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 22074000.00
MEDP balance_sheet (annual, 2022-12-31) — Properties: 0.00
MEDP cash_flow (annual, 2022-12-31) — Purchase Of PPE: -36879000.00
MEDP balance_sheet (annual, 2022-12-31) — Receivables: 253404000.00
MEDP balance_sheet (annual, 2022-12-31) — Receivables Adjustments Allowances: -170000.00
MEDP income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 1027558000.00
MEDP income_statement (annual, 2022-12-31) — Reconciled Depreciation: 22341000.00
MEDP cash_flow (annual, 2022-12-31) — Repayment Of Debt: -274200000.00
MEDP cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -847849000.00
MEDP balance_sheet (annual, 2022-12-31) — Retained Earnings: -359827000.00
MEDP income_statement (annual, 2022-12-31) — Selling General And Administration: 131400000.00
MEDP balance_sheet (annual, 2022-12-31) — Share Issued: 31163267.00
MEDP cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 324200000.00
MEDP cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -274200000.00
MEDP cash_flow (annual, 2022-12-31) — Stock Based Compensation: 21412000.00
MEDP balance_sheet (annual, 2022-12-31) — Stockholders Equity: 386387000.00
MEDP balance_sheet (annual, 2022-12-31) — Tangible Book Value: -314017000.00
MEDP income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 513247.00
MEDP income_statement (annual, 2022-12-31) — Tax Provision: 37492000.00
MEDP income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.13
MEDP balance_sheet (annual, 2022-12-31) — Total Assets: 1352495000.00
MEDP balance_sheet (annual, 2022-12-31) — Total Capitalization: 386387000.00
MEDP balance_sheet (annual, 2022-12-31) — Total Debt: 188867000.00
MEDP balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 386387000.00
MEDP income_statement (annual, 2022-12-31) — Total Expenses: 1181299000.00
MEDP balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 966108000.00
MEDP balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1018533000.00
MEDP balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 162638000.00
MEDP income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 278697000.00
MEDP income_statement (annual, 2022-12-31) — Total Other Finance Cost: 2905000.00
MEDP income_statement (annual, 2022-12-31) — Total Unusual Items: 3859000.00